Hanall Biopharma (009420) — Financial Flexibility Index
Hanall Biopharma (009420) has a Financial Flexibility Index of 0.24x as of September 2025. Free cash flow of ₩10.61 Billion (operating CF ₩7.34 Billion minus capex ₩3.27 Billion) represents 0% of total liabilities (₩44.17 Billion). Also explore Hanall Biopharma equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hanall Biopharma Financial Flexibility Index (2011–2024)
Historical Financial Flexibility Index trend for Hanall Biopharma across 14 annual periods. Check Hanall Biopharma strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Hanall Biopharma (2011–2024)
Year-by-year free cash flow to debt coverage for Hanall Biopharma. For the full company profile including market capitalisation, see Hanall Biopharma (009420) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.73x | ₩32.43 Billion | ₩9.36 Billion | ₩44.53 Billion | ▲ +0.4% |
| 2023 | 0.73x | ₩38.84 Billion | ₩29.64 Billion | ₩53.53 Billion | ▲ +17.0% |
| 2022 | 0.62x | ₩28.03 Billion | ₩25.20 Billion | ₩45.19 Billion | ▲ +298.5% |
| 2021 | 0.16x | ₩5.45 Billion | ₩839.87 Million | ₩34.99 Billion | ▲ +73.2% |
| 2020 | 0.09x | ₩3.49 Billion | ₩929.29 Million | ₩38.86 Billion | ▼ -79.7% |
| 2019 | 0.44x | ₩22.61 Billion | ₩20.49 Billion | ₩50.97 Billion | ▲ +1972.5% |
| 2018 | -0.02x | ₩-1.08 Billion | ₩-2.99 Billion | ₩45.39 Billion | ▼ -103.1% |
| 2017 | 0.76x | ₩43.87 Billion | ₩42.14 Billion | ₩57.50 Billion | ▲ +94.7% |
| 2016 | 0.39x | ₩7.98 Billion | ₩3.95 Billion | ₩20.37 Billion | ▲ +461.3% |
| 2015 | 0.07x | ₩1.53 Billion | ₩-454.02 Million | ₩21.91 Billion | ▲ +228.4% |
| 2014 | -0.05x | ₩-2.25 Billion | ₩-3.52 Billion | ₩41.36 Billion | ▲ +37.1% |
| 2013 | -0.09x | ₩-3.30 Billion | ₩-7.78 Billion | ₩38.23 Billion | ▼ -190.0% |
| 2012 | 0.10x | ₩4.38 Billion | ₩2.20 Billion | ₩45.60 Billion | ▼ -32.9% |
| 2011 | 0.14x | ₩7.84 Billion | ₩7.41 Billion | ₩54.75 Billion | — |